Krilogy Financial LLC Acquires New Stake in STERIS plc $STE

Krilogy Financial LLC acquired a new stake in STERIS plc (NYSE:STE) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 4,847 shares of the medical equipment provider’s stock, valued at approximately $1,179,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Steigerwald Gordon & Koch Inc. bought a new position in shares of STERIS in the third quarter worth about $25,000. Spurstone Advisory Services LLC bought a new stake in STERIS during the 2nd quarter valued at about $29,000. Cloud Capital Management LLC purchased a new stake in STERIS in the 3rd quarter valued at about $29,000. Geneos Wealth Management Inc. grew its stake in STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 104 shares in the last quarter. Finally, TruNorth Capital Management LLC purchased a new position in shares of STERIS during the third quarter worth approximately $37,000. 94.69% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Six analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, STERIS currently has an average rating of “Moderate Buy” and a consensus price target of $275.20.

STERIS Trading Up 0.5%

NYSE STE opened at $244.58 on Friday. STERIS plc has a one year low of $204.90 and a one year high of $269.44. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48. The company has a market capitalization of $23.99 billion, a price-to-earnings ratio of 34.11 and a beta of 1.03. The company’s 50-day simple moving average is $257.13 and its two-hundred day simple moving average is $250.20.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. During the same quarter in the prior year, the firm earned $2.32 EPS. The company’s revenue was up 9.2% compared to the same quarter last year. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th will be issued a $0.63 dividend. The ex-dividend date is Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS’s payout ratio is currently 35.15%.

Insider Activity

In other news, VP Julia Madsen sold 5,008 shares of the firm’s stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $262.00, for a total value of $1,312,096.00. Following the sale, the vice president directly owned 10,710 shares in the company, valued at approximately $2,806,020. This trade represents a 31.86% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Renato Tamaro sold 5,036 shares of STERIS stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the completion of the transaction, the vice president directly owned 5,695 shares in the company, valued at approximately $1,466,747.25. The trade was a 46.93% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.07% of the company’s stock.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.